3QD Pill - yellow capsule/oblong, 21mm

Generic Name: dasabuvir/ombitasvir/paritaprevir/ritonavir

Pill with imprint 3QD is Yellow, Capsule/Oblong and has been identified as Viekira XR dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg. It is supplied by AbbVie Inc.

Viekira XR is used in the treatment of Hepatitis C and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Viekira XR dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 3QD

Viekira XR

Generic Name: dasabuvir/ombitasvir/paritaprevir/ritonavir
Imprint: 3QD
Strength: dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg
Color: Yellow
Size: 21.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Antiviral combinations
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: AbbVie Inc.
National Drug Code (NDC): 00074-0063 (Discontinued)
Inactive Ingredients: copovidone, silicon dioxide, magnesium silicate, titanium dioxide, polyethylene glycol 3350, sorbitan monolaurate, tocophersolan, hypromellose 2208 (15000 mPa.s), magnesium stearate, hypromellose 2910 (6 mPa.s), hypromellose 2910 (15 mPa.s), polyethylene glycol 400, polysorbate 80, ferric oxide yellow, hydroxypropyl cellulose (type l)
Note: Inactive ingredients may vary.